Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells
Authors:
- 15 January 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (2) , 581-590
Abstract
Purpose: Neuropilin (Np)-1 and -2 are coreceptors for vascular endothelial growth factor (VEGF). This study was designed to assess their role in pancreatic ductal adenocarcinoma (PDAC). Experimental Design: We assessed Np-1 and Np-2 expression by real-time quantitative PCR in relation to the expression of VEGF ligands and receptors in pancreatic cancer cell lines and tissues. Results: ASPC-1, CAPAN-1, and PANC-1 pancreatic cancer cells and tumor-derived, laser-captured pancreatic cancer cells exhibited higher Np-1 and Np-2 mRNA levels than VEGF receptor-1, -2, or -3 mRNA levels. Transfection of Np-1 and Np-2 cDNAs in COS-7 cells, and treatment with tunicamycin revealed that both proteins were glycosylated. Both proteins were expressed in pancreatic cancer cell lines, in the PDAC samples, and in acinar cells adjacent to the cancer cells. The normal pancreas was devoid of Np-1 immunoreactivity, whereas Np-2 immunoreactivity was present in the endocrine islets and in some acinar cells, but not in ductal cells. Conclusions: The aberrant localization of Np-1 and Np-2 in the cancer cells in PDAC suggests that in addition to exerting proangiogenic effects, these coreceptors may contribute to novel autocrine-paracrine interactions in this malignancy.Keywords
This publication has 42 references indexed in Scilit:
- Neuropilin‐2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumoursThe Journal of Pathology, 2002
- A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune responseNature Immunology, 2002
- Neuropilin-1 Participates in Wound AngiogenesisThe American Journal of Pathology, 2002
- Vascular Endothelial Growth Factor Receptor-1 and Neuropilin-2 Form ComplexesJournal of Biological Chemistry, 2001
- Pancreatic cancer cell-derived vascular endothelial growth factor is biologically activein vitro and enhances tumorigenicityin vivoInternational Journal of Cancer, 2001
- Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121Journal of Biological Chemistry, 2001
- The interaction of Neuropilin-1 with Vascular Endothelial Growth Factor and its receptor Flt-1Journal of Biological Chemistry, 2000
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992